Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Velos continues adding CTSA customers - 40% now use Velos products



FREMONT, Calif., June 30, 2015 /PRNewswire/ -- Velos, Inc., the pioneering software company for clinical research and specialty medicine, continues to grow and add customers who receive Clinical and Translational Science Awards ("CTSAs").  More than 40% of the 62 CTSAs awarded by the National Institutes of Health currently use Velos software for clinical research information management. This is among the largest such market shares in its product class. 

"Our presence in the CTSA community keeps growing as a result of our continued intense focus on the particular challenges and needs of this very important group of clinical researchers," says John S. McIlwain, President of Velos.

As clinical studies continue to increase in complexity, it is more challenging than ever to ensure that efficiency and compliance are being addressed and that patients are being treated in the most ethical manner possible. Velos helps research organizations address these issues through an integrated platform that enables management of the entire clinical research portfolio across multiple departments and sites, while also establishing a powerful foundation designed with industry standards, scalability and interoperability in mind. The return on investment is vast and varied, including faster study setup and turnaround time, improved accrual, increased regulatory compliance, more accurate and comprehensive research billing, reduced staff workloads, and higher data quality. Velos' solutions provide the CTSA community with a platform that creates an efficient and connected ecosystem and promotes administrative and scientific excellence while ensuring a strong, scalable and adaptable solution for their evolving needs.

Velos expects continued growth in the CTSA community through its flagship Velos eResearch product as well as Velos eResearch sister products for clinical research and translational medicine.  What's more, over the last several years the company has made major R&D investments to further extend the value and utility of its core clinical research product line. These innovations are scheduled to hit the market later in 2015 and beyond.

About Velos:

Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the world. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. Velos integrates the clinical, administrative and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California.

 

SOURCE Velos, Inc.


These press releases may also interest you

at 00:01
AirTies, the most widely deployed provider of managed Wi-Fi Mesh solutions to global service providers, announced today has opened a new R&D center in Austin, Texas, including a new test home that replicates real-world usage of in-home Wi-Fi to...

at 00:01
WatchGuard® Technologies, a leader in advanced network security solutions, today announced the findings of its quarterly Internet Security Report, which explores the latest computer and network security threats affecting small to midsize businesses...

at 00:00
Eurofins Digital Testing, a global leader in end-to-end quality assurance (QA) and testing services, today announced that Hisense has committed to Eurofins' 4K HDR Ultra HD logo technical requirements in its products....

12 déc 2017
JA Solar Holdings Co., Ltd., one of the world's largest manufacturers of high-performance solar power products, today announces the output power of its 60-cell PV modules assembled by mono-Si PERC cells has exceeded 325W. The actual output power of...

12 déc 2017
CineAsia 2017 kicked off in Hong Kong on December 11, 2017. How to leverage advanced technology to achieve intelligent projection and efficient operation for cinemas became a hot topic in the projection industry. During the event, CINEAPPO, a leading...

12 déc 2017
HITLAB, in association with StartHealth, an initiative of Unitus Seed Fund and part of India's leading impact venture fund investing in early-stage startups innovating for the masses, today announced the 2018 HITLAB World Cup: India. Innovators...




News published on 30 june 2015 at 18:26 and distributed by: